Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CEAD | Option to purchase common stock | Award | +2K | 2K | Mar 11, 2022 | Common Stock | 2K | $2.20 | Direct | F1 | |||
transaction | CEAD | Option to purchase common stock | Award | +3K | 3K | Mar 11, 2022 | Common Stock | 3K | $2.20 | Direct | F2 | |||
transaction | CEAD | Option to purchase common stock | Award | +5K | 5K | Mar 11, 2022 | Common Stock | 5K | $2.20 | Direct | F3 | |||
transaction | CEAD | Option to purchase common stock | Award | +5K | 5K | Mar 11, 2022 | Common Stock | 5K | $2.20 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents the grant of non-qualified stock options to purchase 2,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vested and exercisable on the date of grant. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act. |
F2 | Represents the grant of non-qualified stock options to purchase 3,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2023. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act. |
F3 | Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2024. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act. |
F4 | Represents the grant of non-qualified stock options to purchase 5,000 shares of common stock at an exercise price of $2.20, the closing price of the Issuer's common stock on March 10, 2022, which were vest and become exercisable on March 11, 2025. These options were granted in connection with the Reporting Person's appointment as the Company's CFO, Treasurer and Secretary. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act. |